About
Company Management
Board of Directors
Scientific Advisory Board
Clinical Advisory Board
Timeline
Careers
Technologies
REQORSA™ Immunogene Therapy
GPX-002
ONCOPREX® Nanoparticle Delivery System
Programs
Oncology Combination Treatment Approach
Lung Cancer
Diabetes
Clinical Trials
Pipeline
ONC-001
ONC-002
Acclaim-1
Acclaim-2
DIA-001
Expanded Access Policy
Investors
Overview
Company Profile
Stock Information
SEC Filings
Analyst Coverage
Corporate Governance
Shareholder FAQ
Downloads
Events
News
Press Releases
Blog Posts
Media Coverage
Videos
Email Alerts
Contact
About
Company Management
Board of Directors
Scientific Advisory Board
Clinical Advisory Board
Timeline
Careers
Technologies
REQORSA™ Immunogene Therapy
GPX-002
ONCOPREX® Nanoparticle Delivery System
Programs
Oncology Combination Treatment Approach
Lung Cancer
Diabetes
Clinical Trials
Pipeline
ONC-001
ONC-002
Acclaim-1
Acclaim-2
DIA-001
Expanded Access Policy
Investors
Overview
Company Profile
Stock Information
SEC Filings
Analyst Coverage
Corporate Governance
Shareholder FAQ
Downloads
Events
News
Press Releases
Blog Posts
Media Coverage
Videos
Email Alerts
Contact
© 2021 © 2020 Genprex Inc. All Rights Reserved.
About Us
Board of Directors
James E. Rothman, PhD
Strategic Advisor to the Board of Directors
Brent Longnecker
Board Director
Jose A. Moreno Toscano
Board Director
William Wilson, Jr.
Board Director
